Technologies

No. 11/2024 – Managers’ transactions

  • by

Nasdaq Copenhagen                                                                                    Nikolaj Plads 6 DK-1067 Copenhagen K    Copenhagen, 4 September 2024 ANNOUNCEMENT no. 11/2024 Managers’ transactions Pursuant to Article 19 of the market abuse regulation Cemat A/S hereby announces the following information received… Read More »No. 11/2024 – Managers’ transactions

iRhythm Technologies Enters License Agreement with BioIntelliSense for Multiparameter Sensor Technology to be Used in Ambulatory Cardiac Monitoring

  • by

iRhythm granted exclusive license to BioIntelliSense’s patented pulse oximetry, accelerometry and trending non-invasive blood pressure technologies for use within ambulatory cardiac monitoring (ACM) market SAN FRANCISCO, Sept. 04, 2024 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc.… Read More »iRhythm Technologies Enters License Agreement with BioIntelliSense for Multiparameter Sensor Technology to be Used in Ambulatory Cardiac Monitoring